Impact of COVID-19 vaccination in post-COVID cardiac complications

被引:6
|
作者
Parodi, Josefina B. [1 ,3 ]
Indavere, Agustin [1 ]
Jacob, Pamela Bobadilla [1 ]
Toledo, Guillermo C. [1 ]
Micali, Ruben G. [1 ]
Waisman, Gabriel [1 ]
Masson, Walter [2 ]
Epstein, Eduardo D. [1 ]
Huerin, Melina S. [1 ]
机构
[1] Inst Cardiovasc Lez, Buenos Aires, Argentina
[2] Hosp Italiano Buenos Aires, Ciudad Autonoma Buenos Aires, Buenos Aires, Argentina
[3] Inst Cardiovasc Lez, Argentina Lez 3021, RA-1642 Buenos Aires, Argentina
关键词
COVID-19; SARS-CoV-2; Post-acute COVID-19 syndrome; Myocarditis; Cardiomyopathy; Echocardiography; Vaccination; CORONAVIRUS DISEASE 2019;
D O I
10.1016/j.vaccine.2023.01.052
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: After the acute infection, COVID-19 can produce cardiac complications as well as long-COVID persistent symptoms. Although vaccination against COVID-19 represented a clear reduction in both mortality and ICU admissions, there is very little information on whether this was accompanied by a decrease in the prevalence of post-COVID cardiac complications. The aim of this study was to analyze the relationship between COVID-19 vaccination and the prevalence of post-COVID cardiac injury assessed by echocardiogram, and long-COVID persistent cardiac symptoms. Methods: All patients who consulted for post-COVID evaluation 14 days after discharge from acute illness were included. Patients with heart disease were excluded. The relationship between complete vaccination scheme (at least two doses applied with 14 days or more since the last dose) and pathological echocardiographic findings, as well as the relationship of vaccination with persistent long-COVID symptoms, were evaluated by multivariate analysis, adjusting for age, sex and clinical variables that would have shown significant differences in uni-variate analysis. Results: From 1883 patients, 1070 patients (56.8%) suffered acute COVID-19 without a complete vaccination scheme. Vaccination was associated with lower prevalence of cardiac injury (1.35% versus 4.11%, adjusted OR 0.33; 95% CI 0.17-0.65, p=0.01). In addition, vaccinated group had a lower prevalence of persistent long-COVID symptoms compared to unvaccinated patients (10.7% versus 18.3%, adjusted OR 0.52; 95% CI 0.40-0.69, p<0.001). Conclusion: Vaccination against COVID-19 was associated with lower post-COVID cardiac complications and symptoms, reinforcing the importance of fully vaccinating the population.(c) 2023 Elsevier Ltd. All rights reserved.
引用
收藏
页码:1524 / 1528
页数:5
相关论文
共 50 条
  • [41] Post COVID-19 medical complications
    Zaidi, Asfia
    Ahmad, Iffat Zareen
    Khan, Elhan
    Tabassum, Heena
    ANNALS OF PHYTOMEDICINE-AN INTERNATIONAL JOURNAL, 2021, 10 : 63 - 70
  • [42] The impact of COVID-19 and COVID vaccination on cardiovascular outcomes
    Akhtar, Zubair
    Trent, Mallory
    Moa, Aye
    Tan, Timothy C.
    Froebert, Ole
    MacIntyre, C. Raina
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2023, 25 : A42 - A49
  • [43] Effctiveness of Post-COVID rehabilitation and impact of frailty in Post-COVID Syndrome
    Akinlabi, Kola
    Patel, Binny
    Barfa, Ana-Maria
    Mallia, Patrick
    Trojak, Radoslav
    Ukaere, Amalachukwu
    Sandercock, Gavin
    EUROPEAN RESPIRATORY JOURNAL, 2023, 62
  • [44] Renal Complications Following COVID-19 Vaccination
    Jadali, Zohreh
    UROLOGY JOURNAL, 2023, 20 (04) : 281 - 282
  • [45] Neurological Complications Following COVID-19 Vaccination
    Chatterjee, Aparajita
    Chakravarty, Ambar
    CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS, 2023, 23 (01) : 1 - 14
  • [46] Neurological Complications after COVID-19 Vaccination
    Khalimova K.M.
    Rashidova N.S.
    Salimjonov J.J.
    Neuroscience and Behavioral Physiology, 2024, 54 (4) : 540 - 546
  • [47] Neurological Complications Following COVID-19 Vaccination
    Aparajita Chatterjee
    Ambar Chakravarty
    Current Neurology and Neuroscience Reports, 2023, 23 : 1 - 14
  • [48] Acantholytic Dyskeratosis Post-COVID Vaccination
    Yang, Kevin
    Prussick, Lisa
    Hartman, Rebecca
    Mahalingam, Meera
    AMERICAN JOURNAL OF DERMATOPATHOLOGY, 2022, 44 (06) : E61 - E63
  • [49] COVID-19 Recovery: Consistent Absence of Cerebrospinal Fluid Biomarker Abnormalities in Patients With Neurocognitive Post-COVID Complications
    Kanberg, Nelly
    Grahn, Anna
    Stentoft, Erika
    Bremell, Daniel
    Yilmaz, Aylin
    Studahl, Marie
    Nilsson, Staffan
    Schoell, Michael
    Gostner, Johanna M.
    Blennow, Kaj
    Zetterberg, Henrik
    Padmanabhan, Nikhil
    Cohen, Rachel
    Misaghian, Salvia
    Romero, Daniel
    Campbell, Christopher
    Mathew, Anu
    Wang, Mingyue
    Sigal, George
    Stengelin, Martin
    Eden, Arvid
    Gisslen, Magnus
    JOURNAL OF INFECTIOUS DISEASES, 2024, 229 (02): : 493 - 501
  • [50] Complications after discharge with COVID-19 infection and risk factors associated with development of post-COVID pulmonary fibrosis
    Aul, Raminder
    Gates, Jessica
    Draper, Adrian
    Dunleavy, Anne
    Ruickbie, Sachelle
    Meredith, Helen
    Walters, Nicola
    van Zeller, Cristiano
    Taylor, Victoria
    Bridgett, Michael
    Dunwoody, Roisin
    Grubnic, Sisa
    Jacob, Tersesa
    Ong, Yee Ean
    RESPIRATORY MEDICINE, 2021, 188